Company: CDT
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001641172-25-024140
Chunk: 39

Company: CDT Equity Inc.
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 1
Chunk 39
---
 costs in subsequent periods as the forfeitures
arise.

The
following table summarizes stock option activity for the 2023 Plan:

Schedule
of Stock Option Activity 

    Number of Options  
    Weighted Average Exercise Price  
    Weighted Average Remaining Contractual Term (years)  
    Aggregate Intrinsic Value (in thousands) 
  
    Outstanding at December 31, 2024 
     4,367  
    $1,223  
     9.72  
    $- 
  
    Granted 
     -  
    $-  
     -  
    $- 
  
    Cancelled/forfeited 
     (337) 
    $1,484  
     -  
    $- 
  
    Exercised 
     -  
    $-  
     -  
    $- 
  
    Outstanding at June 30, 2025 
     4,030  
    $1,201  
     8.96  
    $- 
  
    Exercisable 
     1,516  
    $1,134  
     9.23  
    $- 
  
    Unvested 
     2,514  
    $1,270  
     8.85  
    $- 

The
aggregate intrinsic value of options is calculated as the difference between the exercise price of the underlying options and the fair
value of the Company’s Common Stock for those options that had exercise prices lower than the fair value of the Company’s
Common Stock. As of June 30, 2025, the total compensation cost related to non-vested option awards not yet recognized was $1.6 million
with a weighted average remaining vesting period of 1.41 years.

For
the three months ended June 30, 2025 and June 30, 2024, there was a total of $0.2 million and $0.5 million, respectively in stock-based
compensation expense recognized within General and Administrative expenses on the condensed consolidated statements of operations and
comprehensive loss, respectively.

For
the six months ended June 30, 2025 and June 30, 2024, there was a total of $0.4 million and $0.9 million, respectively in stock-based
compensation expense recognized within General and Administrative expenses on the condensed consolidated statements